The relevance of synuclein autoantibodies as a biomarker for Parkinson’s disease
Authors Garg P, Maass F, Sundaram SM, Mollenhauer B, Mahajani S, van Riesen C, Kügler S, Bähr M Journal Molecular and Cellular Neuroscience Citation Mol Cell Neurosci. 2022 Jun 2:103746. Abstract Several studies have investigated if the levels of α-synuclein autoantibodies (α-syn AAb) differ in serum of Parkinson’s disease (PD)